✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals
Market Cap
₹89,516 Cr.
P/E
24.20
  • Lupin
  • Zydus Lifesciences
  • Mankind Pharma
  • TJI Pharma
FAQs on Lupin Ltd. Shareprice

Lupin has given better returns compared to its competitors.
Lupin has grown at ~35.55% over the last 2yrs while peers have grown at a median rate of 18.61%

Lupin is not expensive.
Latest PE of Lupin is 24.2, while 3 year average PE is 58.06.
Also latest EV/EBITDA of Lupin is 15.92 while 3yr average is 33.16.

Growth Table
  • Lupin Ltd.
  • Zydus Lifesciences
  • Mankind Pharma
Balance Sheet
  • Lupin Ltd.
  • Zydus Lifesciences
  • Mankind Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Lupin Ltd.
  • Zydus Lifesciences
  • Mankind Pharma
Cash Flow
  • Lupin Ltd.
  • Zydus Lifesciences
  • Mankind Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Lupin Ltd.
  • Zydus Lifesciences
  • Mankind Pharma
Quarterly Results
  • Lupin Ltd.
  • Zydus Lifesciences
  • Mankind Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Lupin Ltd. Financials

Balance sheet of Lupin is strong.
It shouldn't have solvency or liquidity issues.

The debt of Lupin is decreasing.
Latest debt of Lupin is -₹1,185.51 Crs as of Mar-25.
This is less than Mar-24 when it was ₹286 Crs.

Yes, profit is increasing.
The profit of Lupin is ₹3,722 Crs for TTM, ₹3,282 Crs for Mar 2025 and ₹1,914 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Lupin latest dividend payout ratio is 16.7% and 3yr average dividend payout ratio is 26.02%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech